Cozart Bioscience , Ltd.

Cozart Bioscience , Ltd. — FDA 510(k) Submissions

Cozart Bioscience , Ltd. has submitted 6 FDA 510(k) premarket notifications since 2001, of which 6 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Methadone, Enzyme Immunoassay, Opiates, Enzyme Immunoassay, Nicotine And Nicotine Metabolites, Cholinesterase Test Paper, Enzyme Immunoassay, Cocaine And Cocaine Metabolites . Use the specialty filter in the sidebar to narrow results.